US-based Ceribell has launched an FDA-approved rapid response EEG system that offers around-the-clock bedside EEG monitoring with instantaneous seizure detection and alert.

The device, Clarity, reduces the time taken to set-up to EEG to under 10 minutes from an average of 4 hours, making EEG possible for critically ill patients.

Claimed to be the most accurate EEG monitoring system, Ceribell’s Rapid Response EEG system provides continuous bedside monitoring with instantaneous seizure detection and alert for consecutive seizures.

In 2017, Ceribell EEG System received FDA 510(k) clearance and is now commercially available in the US.

Ceribell CEO Jane Chao said: “As we continue to drive innovation in the field of encephalography, we are excited to bring the Clarity technology to our Rapid Response EEG System for our customers.”

“When it comes to EEG, there are significant unmet needs for greater access, efficiency, and cost-effectiveness. Clarity will empower hospitals to have the very best in 24 / 7 acute care EEG capability, at a fraction of the cost of conventional systems.

“For the first time, it is possible for physicians to detect non-convulsive status epilepticus within minutes instead of waiting hours or days, allowing them to provide the best care available so they can minimize secondary brain injury.”

The Ceribell Rapid Response EEG System consists of a 10-electrode (8-channel) headband, an EEG recorder with the Brain Stethoscope feature, as well as a cloud portal for continuous seizure monitoring, EEG data storing and remote EEG reviewing.

Featuring Brain Stethoscope and Clarity features, EEG interpretation for spot-checking and continuous seizure detection are possible within seconds.